Assessment of Prevalence and Clinical Features of COVID-19 in Patients Undergoing Maintenance Hemodialysis: Reports from Two Hemodialysis Centers in Iran
Since the outbreak of COVID-19 in December 2019, patients with End-Stage Kidney Disease (ESKD) have been deemed one of the most vulnerable populations due to their numerous comorbidities.
The study was a retrospective cohort study conducted between March 2nd, 2020, and September 21st, 2020. It included 240 patients who underwent MHD at Shahid Beheshti and Vali-Asr Hospitals affiliated with Abadan University of Medical Sciences. Out of these patients, 44 were diagnosed with COVID-19 based on their Reverse transcriptase polymerase chain reaction (rRT-PCR) test results or chest CT scan findings. Demographic, clinical, laboratory and radiologic findings of these patients were collected.
COVID-19 was diagnosed in 44 individuals, which accounts for 18.33%, and eight patients have died, which is 18.1% of the total COVID-19 cases. A total of 39 patients were tested through rRT-PCR, out of which 15 (34.09%) tested positive. Among the 44 patients, 26 were males (59.09%), and 18 were females (40.9%). The most common symptoms were fever (36.36%), shortness of breath (34.09%), cough (25%), and fatigue (13.63%). Additionally, 18.18% of patients were asymptomatic. Chest CT scans revealed ground glass opacity, consolidation, and pleural effusion in 54.83%, 48.38%, and 29.03% of cases, respectively. However, it was normal in 9.67% of patients. Peripheral and central pulmonary involvement was found in 70.96% and 19.35% of patients, respectively. The mean single pool KT/V (SpKT/V) was calculated as 1.10±0.39.
Based on our findings, the COVID-19 outbreak is a significant cause for concern for in-center hemodialysis patients. These individuals are particularly vulnerable due to their underlying health conditions. Furthermore, the limitations in maintaining social distancing, increased public exposure, and pre-existing lung involvement in these patients can further complicate their management and potentially impact their overall outcome.
پرداخت حق اشتراک به معنای پذیرش "شرایط خدمات" پایگاه مگیران از سوی شماست.
اگر عضو مگیران هستید:
اگر مقاله ای از شما در مگیران نمایه شده، برای استفاده از اعتبار اهدایی سامانه نویسندگان با ایمیل منتشرشده ثبت نام کنید. ثبت نام
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.